Form D · Biotechnology
Amerstem, Inc.
Camarillo, CA · CIK 0001635231
Offering snapshot reported Mar 6, 2015 · SEC filing
- Reported sold
- $375K Offering amount: $875K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 20, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 6, 2015 | Initial | $375,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 05
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-235331
The purchaser acquired the equity securities with a value of $375,000. The purchaser has not exercised its option to purchase a Warrant exercisable for additional equity securities at this time.
Source: Form D, filed Mar 6, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jason Bradenberger | Director |
| Jaime Flores Riveros | Director, Executive |
| Maria Del Rocio Sierra Honigmann | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4022 Camino Ranchero, Unit G
Camarillo, CA, 93012
Camarillo, CA, 93012